News

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
The global cardiac surgery devices market is estimated to be worth USD 1.8 billion in 2024 and is projected to grow at a CAGR ...
St. Luke’s Heart and Vascular team became the first in the region to perform a transcatheter tricuspid valve replacement ...
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves ...
Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...
The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
Abbott has scored FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR) system, giving fresh hope to ...
The Harmony Transcatheter Pulmonary Valve is a cutting-edge valve-replacement procedure, where an expandable valve was ...
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) ...
Progress with transcatheter tricuspid valve replacement (TTVR) candidate devices Topaz, LuX-Valve Plus, VDyne, and Trisol for ...
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.